HYDROXYZINE HYDROCHLORIDE
- Product NDC
- 80425-0590
- Requested package NDC
- 80425-0590-1
- 11-digit product format
- 804250590
- Labeler code
- 80425
- Product ID
- 80425-0590_5648abd7-f01a-43fb-e063-6294a90ab817
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- hydroxyzine hydrochloride
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Advanced Rx of Tennessee, LLC
- Application
- ANDA217652
- Marketing category
- ANDA
- Marketing start
- 2026-07-10
- Substance
- HYDROXYZINE DIHYDROCHLORIDE
- Active strength
- 25 mg/1
- Pharmacologic classes
- Antihistamine [EPC]; Histamine Receptor Antagonists [MoA]
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A217652-001 | HYDROXYZINE HYDROCHLORIDE | HYDROXYZINE HYDROCHLORIDE | 10MG | TABLET / ORAL | AB | 2023-08-17 | |
| A217652-002 | HYDROXYZINE HYDROCHLORIDE | HYDROXYZINE HYDROCHLORIDE | 25MG | TABLET / ORAL | AB | 2023-08-17 | |
| A217652-003 | HYDROXYZINE HYDROCHLORIDE | HYDROXYZINE HYDROCHLORIDE | 50MG | TABLET / ORAL | AB | RS | 2023-08-17 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A217652-001 | AB |
| A217652-002 | AB |
| A217652-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A217652-001 | HYDROXYZINE HYDROCHLORIDE | 10MG | TABLET / ORAL | AB | 2023-08-17 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A217652-002 | HYDROXYZINE HYDROCHLORIDE | 25MG | TABLET / ORAL | AB | 2023-08-17 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A217652-003 | HYDROXYZINE HYDROCHLORIDE | 50MG | TABLET / ORAL | AB | RS | 2023-08-17 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A217652-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A217652-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A217652-003 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| HYDROXYZINE HYDROCHLORIDE | HYDROXYZINE HYDROCHLORIDE | St. Mary's Medical Park Pharmacy | 30b6f7b3-b620-961a-e063-6394a90a487b | 2026-07-23 | Warnings, Adverse reactions | 217652 ANDA217652 |
| HYDROXYZINE HYDROCHLORIDE | HYDROXYZINE HYDROCHLORIDE | Advanced Rx of Tennessee, LLC | 5648abce-f20e-717c-e063-6294a90a88ac | 2026-07-10 | Warnings, Adverse reactions | 217652 ANDA217652 80425-0590-1 80425-0590 80425059001 |
| HYDROXYZINE HYDROCHLORIDE | HYDROXYZINE HYDROCHLORIDE | Bryant Ranch Prepack | 66be7bde-d2bd-4c65-bde9-0fb9f5be093f | 2026-07-02 | Warnings, Adverse reactions | 217652 ANDA217652 |
| HYDROXYZINE HYDROCHLORIDE | HYDROXYZINE HYDROCHLORIDE | NuCare Pharmaceuticals, Inc. | 534a6a49-23df-d65e-e063-6294a90a1a12 | 2026-06-02 | Warnings, Adverse reactions | 217652 ANDA217652 |
| HYDROXYZINE HYDROCHLORIDE | HYDROXYZINE HYDROCHLORIDE | NuCare Pharmaceuticals, Inc. | 52fb8616-7d4e-9c37-e063-6294a90a1112 | 2026-05-29 | Warnings, Adverse reactions | 217652 ANDA217652 |
| HYDROXYZINE HYDROCHLORIDE | HYDROXYZINE HYDROCHLORIDE | Coupler LLC | 519e54e0-a613-e7b3-e063-6294a90a4452 | 2026-05-12 | Warnings, Adverse reactions | 217652 ANDA217652 |
| HYDROXYZINE HYDROCHLORIDE | HYDROXYZINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | 7edd582c-039c-4bdc-bf8a-61eac8a5a9a0 | 2026-05-11 | Warnings, Adverse reactions | 217652 ANDA217652 |
| HYDROXYZINE HYDROCHLORIDE | HYDROXYZINE HYDROCHLORIDE | Proficient Rx LP | ca843456-0c93-41e8-9bbc-9cd92447f092 | 2026-05-01 | Warnings, Adverse reactions | 217652 ANDA217652 |
| HYDROXYZINE HYDROCHLORIDE | HYDROXYZINE HYDROCHLORIDE | REMEDYREPACK INC. | f6ad4729-b291-42c4-8483-99385d8043db | 2026-04-09 | Warnings, Adverse reactions | 217652 ANDA217652 |
| HYDROXYZINE HYDROCHLORIDE | HYDROXYZINE HYDROCHLORIDE | NuCare Pharmaceuticals, Inc | 4aa896b1-4fd5-513e-e063-6294a90ab950 | 2026-02-12 | Warnings, Adverse reactions | 217652 ANDA217652 |
| HYDROXYZINE HYDROCHLORIDE | HYDROXYZINE HYDROCHLORIDE | A-S Medication Solutions | afa74394-c079-4ad3-b555-270fe0de3d62 | 2025-12-02 | Warnings, Adverse reactions | 217652 ANDA217652 |
| HYDROXYZINE HYDROCHLORIDE | HYDROXYZINE HYDROCHLORIDE | A-S Medication Solutions | 69a58bc6-c8a4-48ad-ac77-90fac42e0398 | 2025-12-02 | Warnings, Adverse reactions | 217652 ANDA217652 |
| HYDROXYZINE HYDROCHLORIDE | HYDROXYZINE HYDROCHLORIDE | A-S Medication Solutions | a8525244-2acb-4e3e-9769-bbc90549a188 | 2025-12-02 | Warnings, Adverse reactions | 217652 ANDA217652 |
| HYDROXYZINE HYDROCHLORIDE | HYDROXYZINE HYDROCHLORIDE | A-S Medication Solutions | 87b79b7c-0398-47dc-858d-62e44a1b02f4 | 2025-12-02 | Warnings, Adverse reactions | 217652 ANDA217652 |
| HYDROXYZINE HYDROCHLORIDE | HYDROXYZINE HYDROCHLORIDE | A-S Medication Solutions | a9a133e6-efce-4bdb-9335-49c74e57fafe | 2025-11-01 | Warnings, Adverse reactions | 217652 ANDA217652 |
| HYDROXYZINE HYDROCHLORIDE | HYDROXYZINE HYDROCHLORIDE | Rising Pharma Holdings, Inc. | 6a1a48ac-8ad5-4363-b298-d9825ae2a448 | 2025-08-14 | Warnings, Adverse reactions | 217652 ANDA217652 |
| HYDROXYZINE HYDROCHLORIDE | HYDROXYZINE HYDROCHLORIDE | REMEDYREPACK INC. | 8f41912e-12ce-4174-a0fb-cfb4888d8d58 | 2025-07-16 | Warnings, Adverse reactions | 217652 ANDA217652 |
| HYDROXYZINE HYDROCHLORIDE | HYDROXYZINE HYDROCHLORIDE | Bryant Ranch Prepack | 6577589f-1a80-41d8-847a-70c3f38d8dc0 | 2025-06-02 | Warnings, Adverse reactions | 217652 ANDA217652 |
| HYDROXYZINE HYDROCHLORIDE | HYDROXYZINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | a35d1fe2-328d-42ff-ba1f-18a7f2f03c88 | 2025-05-01 | Warnings, Adverse reactions | 217652 ANDA217652 |
| Hydroxyzine HCL | HYDROXYZINE HCL | Direct_rx | 22049012-733e-6b45-e063-6294a90a670f | 2024-09-13 | Warnings, Adverse reactions | 217652 ANDA217652 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- HYDROXYZINE HYDROCHLORIDE
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| HYDROXYZINE DIHYDROCHLORIDE | 25 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 76755771U3 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 995258 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 5648abce-f20e-717c-e063-6294a90a88ac | Available on FDA.report |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Sample | Status |
|---|---|---|---|---|---|
| 80425-0590-1 | 80425059001 | 30 TABLET, FILM COATED in 1 BOTTLE (80425-0590-1) | 2026-07-10 | 0 | Current |